🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07257367
Recruiting Observational

Pressure Sensing Sheath Blood Pressure Monitoring Compared to Traditional Methods in Interventional Procedures

NCT07257367 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Fourth People's Hospital Tongji University
Phase
Observational
Started
2025-08-01
Last updated
2026-07-14

Condition(s) studied

Blood Pressure MonitoringNeuroendovascular Procedures

Investigational drug(s) / intervention(s)

Pressure Sensing Sheath MonitoringRadial Arterial Line Monitoring

Pressure Sensing Sheath Monitoring: Continuous invasive blood pressure monitoring via pressure sensing sheath inserted through radial artery during interventional procedure. The pressure sensing sheath integrates a miniature pressure sensor within the vascular access sheath, enabling simultaneous vascular access and continuous blood pressure monitoring.

Radial Arterial Line Monitoring: Traditional invasive blood pressure monitoring via radial arterial catheterization (RAC) on the contralateral radial artery, combined with standard non-invasive blood pressure cuff monitoring. This serves as the gold standard comparator for blood pressure measurement accuracy.

Study summary

This observational study aims to evaluate the accuracy and safety of pressure sensing sheath blood pressure monitoring compared to traditional invasive and non-invasive blood pressure monitoring methods during neuroendovascular interventional procedures.

The study will enroll 50 adult patients undergoing elective neuroendovascular procedures requiring general anesthesia and continuous invasive blood pressure monitoring. Blood pressure will be simultaneously measured using three methods: (1) pressure sensing sheath, (2) radial arterial line, and (3) non-invasive cuff monitoring.

The primary outcome is the accuracy of blood pressure measurements from the pressure sensing sheath compared to radial arterial line measurements. Secondary outcomes include the incidence of access site complications, procedure duration, patient comfort scores, and cost-effectiveness analysis.

This prospective, single-center study will be conducted at Shanghai Fourth People's Hospital Affiliated to Tongji University from August 2025 to May 2027.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Patients scheduled for elective transradial interventional procedures requiring continuous invasive blood pressure monitoring * Patients who must undergo radial arterial catheterization for invasive blood pressure monitoring according to clinical needs and standard medical operational procedures * Patients who can understand the study purpose, voluntarily participate and sign informed consent, and are willing to undergo relevant examinations and clinical follow-up Exclusion Criteria: * Contraindications to radial artery access * Hemodynamic instability * Patients requiring postoperative continuous invasive blood pressure monitoring * Failure to obtain informed consent * Known severe aortic or subclavian artery stenosis or occlusion * Severe coagulation dysfunction (INR ≥2.0, platelet count \<75×10⁹/L) * BMI \>40 kg/m² * Severe heart failure (NYHA Class IV) or patients requiring emergency rescue with hemodynamic instability

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai Fourth People's Hospital Tongji University Shanghai Shanghai Municipality Recruiting

More Shanghai Fourth People's Hospital Tongji University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07257367 on ClinicalTrials.gov ↗ ← All trials in China